Joel Greenblatt's ETON Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 15,982 shares of Eton Pharmaceuticals, Inc. (ETON) worth $578,548, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Joel Greenblatt has initiated a new position in ETON, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Eton Pharmaceuticals (ETON) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eton Pharmaceuticals (ETON) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +15,982 | New Buy | 15,982 | $36.20 |
Joel Greenblatt's Eton Pharmaceuticals Investment FAQs
Joel Greenblatt first purchased Eton Pharmaceuticals, Inc. (ETON) in Q2 2026, acquiring 15,982 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Eton Pharmaceuticals, Inc. (ETON) for 1 quarters since Q2 2026.
Joel Greenblatt's largest addition to Eton Pharmaceuticals, Inc. (ETON) was in Q2 2026, adding 15,982 shares worth $578,548.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 15,982 shares of Eton Pharmaceuticals, Inc. (ETON), valued at approximately $578,548.
As of the Q2 2026 filing, Eton Pharmaceuticals, Inc. (ETON) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Eton Pharmaceuticals, Inc. (ETON) was 15,982 shares, as reported at the end of Q2 2026.